Mizuho Maintains Buy-Rating on Questcor Pharma (QCOR), Comments on FTC Concerns
Tweet Send to a Friend
Mizuho Securities maintained a Buy rating on Questcor Pharmaceuticals (NASDAQ: QCOR) with a price target of $93.00. Comments follow negative ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
